Sunshine Heart Announces Change to Presentation Time at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sunshine Heart Announces Change to Presentation Time at Piper Jaffray 26th Annual Healthcare Conference

EDEN PRAIRIE, Minn., Nov. 21, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq: SSH ) announced today that Dave Rosa, Chief Executive Officer, will be presenting at the Piper Jaffray 26 th Annual Healthcare Conference on Wednesday, December 3, 2014 at 10:30 AM EST at The New York Palace Hotel in New York, New York. Mr. Rosa's presentation was originally scheduled for 4:00 PM EST.

About the C-Pulse ® Heart Assist System

The C-Pulse Heart Assist System, or C-Pulse System, an investigational device in the United States, Canada and countries that do not recognize the CE mark approval, utilizes the scientific principles of intra-aortic balloon counterpulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. Combined, these potential benefits may help sustain the patient's current condition or, in some cases, reverse the heart failure process, thereby potentially preventing the need for later-stage heart failure devices, such as left ventricular assist devices (LVADs), artificial hearts or transplants. It may also provide relief from the symptoms of Class III and ambulatory Class IV heart failure and improve quality of life and cardiac function. Based on the results from our feasibility study, we also believe that some patients treated with our C-Pulse System will be able to stop using the device due to sustained improvement in their conditions as a result of the therapy.

Caution: Investigational device, limited by Federal (or United States) Law to Investigational use.

About Sunshine ®  Heart

Sunshine Heart, Inc. (Nasdaq: SSH ) is an early-stage medical device company focused on developing, manufacturing and commercializing the C-Pulse System for treatment of Class III and ambulatory Class IV heart failure. Sunshine Heart has completed an approved U.S. Food and Drug Administration (FDA) feasibility clinical study of the C-Pulse System and presented the results in November 2011. In March 2012, the FDA notified the Company that it could move forward with an investigational device exemption (IDE) application. Sunshine Heart received unconditional approval from the FDA in November 2012 to initiate its pivotal study. In July 2012, Sunshine Heart received CE Mark approval for its C-Pulse System in Europe. Sunshine Heart is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The Company has been listed on the NASDAQ Capital Market since February 2012.

Forward-Looking Statements

Certain statements in this release are forward-looking statements that are based on management's beliefs, assumptions, expectations, and information currently available to management. All statements that address future operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including, without limitation, our expectations with respect to future clinical study activities and results including patient enrollment in studies. These forward-looking statements are subject to numerous risks and uncertainties, including, without limitation, the possibility that our clinical studies do not meet their enrollment goals, meet their endpoints or otherwise fail, that regulatory authorities do not accept our application or approve the marketing of the C-Pulse System, the possibility that we may be unable to raise the funds necessary for the development and commercialization of our products, that we may not be able to commercialize our products successfully in the EU and the other risk factors described under the caption "Risk Factors" and elsewhere in our filings with the Securities and Exchange Commission. You should not place undue reliance on forward-looking statements because they speak only as of the date when made and may turn out to be inaccurate. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

For further information, please contact: Investor: Candice Knoll Blueprint Life Science Group T: +1-415-375-3340 Ext. 105 Jeff Mathiesen Chief Financial Officer Sunshine Heart, Inc. T: +1-952-345-4200 Media: David Schull Russo Partners T: +1-212-845-4271 Christopher Hippolyte Russo Partners T: + 1-646-942-5634

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 105

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Sophia Space Tests the Software Layer for Orbit Ahead

Updated Category News Views 37

Orbit got a little less theoretical when Sophia Space put its operating system across multiple Kepler Communications satellites. That is not a finished orbital data center, despite the inevitable big-language parade around this sort of announcement. It is a software deployment, a real one, aboard Kepler's Tranche 1 optical data relay constellation. In an industry stuffed...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 62

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 112

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
iFLYTEK’s AINOTE Discounts Put E-Ink Utility on Trial

Updated Category News Views 6

A slim E-Ink notebook is getting shoved into the Black Friday brawl, and iFLYTEK is betting that less screen glare and more follow-through can still command a serious price. The company has put discounts of up to 25% on its AINOTE lineup, a sensible move in a gadget season where buyers have no shortage of tablets, voice apps, and half-used productivity subscriptions...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 61

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 167

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 77

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 28

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 83

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading

Top 5 Most Recently Viewed Articles

Radius Insights Launches New Technology Research Practice

Updated Category News Views 131

Radius Insights Launches Radius Tech A focused expansion of Radius' technology expertise aims to help tech brands make smarter, faster growth decisions. Radius Insights recently unveiled the launch of Radius Tech, a dedicated technology division within Radius designed to deliver precise market research and customer insights specifically tailored for technology companies....

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 176

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Gaxos.ai to Skyrocket Connections at Unite 2024 Conference

Updated Category News Views 71

Gaxos.ai's Involvement at Unite 2024 Conference Gaxos.ai Inc. is preparing for a major presence at the Unite 2024 Conference, a vibrant event dedicated to showcasing the latest innovations in gaming and technology. This conference is well-known for bringing together game developers, artists, and tech enthusiasts. Running from September 18 to September 20, Gaxos is eager...

Continue Reading
XNRGY Climate Systems Completes Strategic Growth Financing

Updated Category News Views 365

XNRGY Climate Systems Strengthens Financial Foundation XNRGY Climate Systems, recognized as a key player in sustainable technologies, recently revealed that it has effectively finalized its financing round. This includes a significant investment partnership with Capital Bridge Group and Prologis Ventures. With this move, XNRGY aims to push forward its mission of advancing...

Continue Reading
BioLife Solutions Sells SAVSU to Enhance Logistics Strategy

Updated Category News Views 211

BioLife Solutions Completes Strategic Sale of SAVSU BioLife Solutions, Inc. (Nasdaq: BLFS), a prominent provider of cell processing tools for the cell and gene therapy market, has recently announced a significant event in its operational strategy. The company has sold its wholly owned cold chain logistics subsidiary, SAVSU Cleo Technologies, LLC., previously known as...

Continue Reading